Russell Clayton

Senior VP, R&D, WINDTREE THERAPEUTICS INC /DE/.

Companies

Zafgen (United States)Chief Medical Officer Jul 18, 2023 to now¹
WINDTREE THERAPEUTICS INC /DE/Senior VP, R&D Sep 22, 2011 to Mar 10, 2014²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Zafgen (United States) LRMR71,443 shares³$150.7K at $2.11Jan 26, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 26, 2026Granted 25,637 shares of Zafgen (United States)³
Jan 22, 2025Granted 23,306 shares of Zafgen (United States)⁴
Jan 17, 2024Granted 22,500 shares of Zafgen (United States)⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARZafgen (United States), Chief Medical Officer
2
SEC EDGARWINDTREE THERAPEUTICS INC /DE/, Senior VP, R&D
3
SEC EDGARZafgen (United States) shares after the filing of Jan 26, 2026
4
SEC EDGARForm 4 filed Jan 24, 2025
5
SEC EDGARForm 4 filed Jan 19, 2024